SightfileU.S. market data from official filings
Companies › MOLN
MOLECULAR PARTNERS AG (MOLN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001745114 · EDGAR filings · Updated 2026-07-20
MOLECULAR PARTNERS AG (MOLN) has reported institutional ownership of 8.9%, with 4 institutional managers holding positions valued at $14.2M per the latest 13F reporting period.
Institutional ownership
8.9%
Institutional managers
4
Reported 13F value
$14.2M
Latest updates
- 2026-07-20 — Foreign issuer report (6-K) filed
- 2026-07-07 — Foreign issuer report (6-K) filed
- 2026-07-02 — Foreign issuer report (6-K) filed
- 2026-06-24 — Employee-plan registration (S-8) filed
- 2026-06-01 — Foreign issuer report (6-K) filed
- 2026-05-12 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, MOLECULAR PARTNERS AG has 4 institutional holders and institutional ownership of 8.9%.
Related companies
REIN THERAPEUTICS INC (RNTX) · NEURAXIS INC (NRXS) · PARK DENTAL PARTNERS INC (PARK) · QT IMAGING HLDGS INC (QTI) · Jasper Therapeutics Inc (JSPR) · PASSAGE BIO INC COM NEW (PASG)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.